KLK3 and pachyonychia congenita: For example, Briganti et al. demonstrated that eSRT given before PSA reached 0.5 ng/mL achieved an equivalent oncological outcome to adjuvant radiotherapy in patients with pT3N0 PC, as stated above [10].